Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
27
users have liked this narrative
8
users have commented on this narrative
76
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
97
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Aperam
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
European Decarbonization And Indonesian Rivals Will Erode Margins
Key Takeaways Accelerated decarbonization, new material adoption, and lack of trade protections threaten Aperam's core revenues, market share, and profit margins. Rising environmental costs, overcapacity, and price competition are expected to further pressure earnings and undermine long-term financial resilience.
View narrative
€25.00
FV
4.9% overvalued
intrinsic discount
5.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
Delhivery
AN
AnalystLowTarget
Consensus Narrative from 24 Analysts
Nearshoring Pressures And Rising Capex Will Erode Long-Term Results
Key Takeaways Shifts in global supply chains, regulatory pressures, and changing consumer behavior threaten Delhivery's volume growth, revenue potential, and network utilization over the long term. Sustained investment needs in sustainability, automation, and technology-amid stiff competition-jeopardize prospects for margin expansion and long-term earnings improvement.
View narrative
₹303.68
FV
54.1% overvalued
intrinsic discount
13.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
Camurus
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Rising Global Scrutiny And Generic Competition Will Pressure Pharma Margins
Key Takeaways Global price controls and rising generic competition threaten Camurus' ability to sustain premium pricing and stable margins on core products. Heavy dependence on a few specialty drugs exposes the company to regulatory, reimbursement, and market exclusivity risks, impacting future earnings growth.
View narrative
SEK 690.00
FV
7.1% undervalued
intrinsic discount
29.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
TransAlta
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Oversupplied Energy Markets And Regulatory Hurdles Will Depress Valuations
Key Takeaways Regulatory and policy instability, plus oversupplied markets, pose significant risks to earnings stability and revenue from core assets. Heavy dependence on legacy assets and increased competition in renewables threaten project returns, revenue growth, and balance sheet strength.
View narrative
CA$13.50
FV
23.2% overvalued
intrinsic discount
-7.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
Kokusai Electric
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Chinese Exposure And Rising Compliance Costs Will Shadow Future Chip Equipment While Minor Upsides Emerge
Key Takeaways Overdependence on a concentrated Chinese customer base and rising in-house equipment development by key clients threaten revenue stability and long-term market share. Stricter global regulations and slower technological advancement intensify cost pressures and limit growth, with industry headwinds casting doubt on sustained profitability.
View narrative
JP¥2.80k
FV
9.7% overvalued
intrinsic discount
7.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
IONOS Group
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Mega-scale Cloud Providers Will Squeeze Margins And Market Share
Key Takeaways Intensifying competition from dominant cloud providers, coupled with weak differentiation and price wars, threatens IONOS's market share and long-term profitability. Increased regulatory complexity and reliance on vulnerable SME segments expose IONOS to higher costs, shrinking margins, and heightened risks of revenue stagnation or decline.
View narrative
€32.00
FV
28.7% overvalued
intrinsic discount
7.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
Go Digit General Insurance
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Rising Climate Risks And Costly Competition Will Impair Margins
Key Takeaways Heightened climate, regulatory, and fraud risks will strain profitability, compress margins, and challenge underwriting quality as compliance and claims costs rise. Over-dependence on motor insurance and intensifying competition may limit revenue growth, erode digital advantages, and hamper Go Digit's long-term earnings potential.
View narrative
₹277.01
FV
29.4% overvalued
intrinsic discount
14.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
Enagás
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Accelerating Decarbonization Will Erode Gas Infrastructure Fundamentals
Key Takeaways Ongoing electrification and stricter EU decarbonization policies threaten Enagás' core gas business and undermine long-term asset utilization and returns. Rising capital requirements, uncertain regulatory frameworks, and sluggish hydrogen market development increase risks of reduced dividends and potential asset write-downs.
View narrative
€12.00
FV
9.8% overvalued
intrinsic discount
-77.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
Global Health
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Excessive Hospital Expansion In India Will Heighten Risks
Key Takeaways Heavy expansion and capital outlay bring significant execution and utilization risks, which could compress margins and returns if patient demand fails to meet expectations. Growing digital healthcare adoption, tightening regulations, and increased competition threaten traditional hospital models, exerting persistent pressure on revenue growth and profitability.
View narrative
₹1.00k
FV
38.3% overvalued
intrinsic discount
14.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
Value any company in seconds
Popular companies